Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 217

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Genomics of hypertension: the road to precision medicine

Open access
Padmanabhan, Sandosh, Dominiczak, Anna F. · 2021 · Nature Reviews Cardiology

Abstract

The known genetic architecture of blood pressure now comprises >30 genes, with rare variants resulting in monogenic forms of hypertension or hypotension and >1,477 common single-nucleotide polymorphisms (SNPs) being associated with the blood pressure phenotype. Monogenic blood pressure syndromes predominantly involve the renin–angiotensin–aldosterone system and the adrenal glucocorticoid pathway, with a smaller fraction caused by neuroendocrine tumours of the sympathetic and parasympathetic nervous systems. The SNPs identified in genome-wide association studies (GWAS) as being associated with the blood pressure phenotype explain only approximately 27% of the 30–50% estimated heritability of blood pressure, and the effect of each SNP on the blood pressure phenotype is small. A paucity of SNPs from GWAS are mapped to known genes causing monogenic blood pressure syndromes. For example, a GWAS signal mapped to the gene encoding uromodulin has been shown to affect blood pressure by influencing sodium homeostasis, and the effects of another GWAS signal were mediated by endothelin. However, the majority of blood pressure-associated SNPs show pleiotropic associations. Unravelling these associations can potentially help us to understand the underlying biological pathways. In this Review, we appraise the current knowledge of blood pressure genomics, explore the causal pathways for hypertension identified in Mendelian randomization studies and highlight the opportunities for drug repurposing and pharmacogenomics for the treatment of hypertension. In this Review, Padmanabhan and Dominiczak discuss how genomics has transformed our understanding of blood pressure regulation and hypertension, summarizing the current knowledge of blood pressure genomics and highlighting the opportunities and challenges for drug repurposing and pharmacogenomics for the treatment of hypertension. The genetic architecture of blood pressure encompasses approximately 30 genes, with rare variants involved in blood pressure dysregulation and >1,477 common single-nucleotide polymorphisms (SNPs) associated with blood pressure. Monogenic forms of blood pressure disorders involve both germline and somatic variants, with the latter predominantly seen in patients with neoplasms associated with hypertension. Most of the SNPs identified in genome-wide association studies (GWAS) as being associated with blood pressure are pleiotropic and mapped to non-coding regions of the genome, which makes functional mapping challenging. Although translating GWAS signals into causal mechanisms and clinical applications has been slow, Mendelian randomization studies are substantially improving our understanding of known epidemiological correlations between blood pressure and other traits. Pharmacogenomic studies of drug–gene interactions might offer a route to the early clinical translation of GWAS signals, with two clinical trials involving blood pressure GWAS SNPs currently ongoing. The genetic architecture of blood pressure encompasses approximately 30 genes, with rare variants involved in blood pressure dysregulation and >1,477 common single-nucleotide polymorphisms (SNPs) associated with blood pressure. Monogenic forms of blood pressure disorders involve both germline and somatic variants, with the latter predominantly seen in patients with neoplasms associated with hypertension. Most of the SNPs identified in genome-wide association studies (GWAS) as being associated with blood pressure are pleiotropic and mapped to non-coding regions of the genome, which makes functional mapping challenging. Although translating GWAS signals into causal mechanisms and clinical applications has been slow, Mendelian randomization studies are substantially improving our understanding of known epidemiological correlations between blood pressure and other traits. Pharmacogenomic studies of drug–gene interactions might offer a route to the early clinical translation of GWAS signals, with two clinical trials involving blood pressure GWAS SNPs currently ongoing.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41569-020-00466-4

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 217

Metadata

Authors
Padmanabhan, S., & Dominiczak, A. F.
Venue
Nature Reviews Cardiology
Published
2020-11-20
Volume
18
Issue
4
Pages
235-250
ISSN
  • 1759-5002 (ISSN-L)
  • 1759-5010
OpenAlex
W3103577858
Cited by
217
References
37
FWCI
4.04
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genomics of hypertension: the road to precision medicine. https://app.cochat.ai/papers/10.1038/s41569-020-00466-4
The paper
Padmanabhan, S., & Dominiczak, A. F. (2021). Genomics of hypertension: the road to precision medicine. Nature Reviews Cardiology. https://doi.org/10.1038/s41569-020-00466-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.